North America GMP Cell Therapy Consumables Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem
Description
North America GMP Cell Therapy Consumables Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
The North America GMP cell therapy consumables market is expected to grow from US$ 6,233.00 million in 2022 to US$ 26,093.86 million by 2028; it is estimated to grow at a CAGR of 27.0% from 2022 to 2028.
Growing Regulatory Approvals for Cell and Gene Therapy (CGT) Product Boosts North America GMP Cell
Therapy Consumables Market
The COVID-19 pandemic accelerated the pace of the ongoing developments in cell and gene therapy (CGT). As per the 2019 U.S. Food and Drug Administration (FDA) report, in the last two years, CGT developers submitted ~500 applications to the FDA to initiate clinical trials. Out of those applications, the FDA predicts that ~10-20 CGT products will be approved annually by 2025. Considering the pace with which the therapies are expected to enter the market, the Alliance for Regenerative Medicine expects this industry's revenues to grow at a CAGR of 40% by 2025.
A few of the FDA-approved CGT developments include:
In 2021, FDA approved Breyanzi. Breyanzi is a cell-based gene therapy to treat patients suffering from certain types of large B-cell lymphoma cancer. Each dose is a customized treatment that uses the patient’s T-cells to fight relapsed or refractory disease.
FDA checks the quality of medication products by carefully monitoring manufacturers' compliance with its Current Good Manufacturing Practice (CGMP) regulations. The regulations comprise minimum requirements for the methods, facilities, and controls to be used during the manufacturing, processing, and packing of a product. The regulations confirm that the product is safe for usage and has the ingredients and strength it claims to have. The approval process for new therapy/drug marketing applications includes a review of the manufacturer's compliance with the CGMPs. FDA evaluators and investigators verify whether the firm has the necessary facilities, equipment, and ability to manufacture the drug it intends to market. Therefore, the outlook of the CGT field is promising due to the increased rate of FDA approvals and patient enthusiasm. In addition, continued advances in CGT following GMP will transform the way diseases are treated and modify healthcare delivery on both the individual and industry levels. Hence, the growing regulatory approvals for cell and gene therapy (CGT) product boosts the North America GMP cell therapy consumables market .
Market Overview
North America is one of the most developed regions in the world. North America accounts for the major share of the GMP cell therapy consumables market over the forecast period. The US is expected to hold the major share in the market owing to the surge in drug discovery, increase in R&D activities, and rise in strategic collaborations among market players. Moreover, rising incidences of cancer, infectious diseases, autoimmune disorders, and neurological disorders have augmented the demand for personalized medicine and regenerative medicine, which, in turn, drive the growth of the GMP cell therapy consumables market. The US holds a significant share of the North America GMP cell therapy consumables market. The market growth is due to rising government health expenditure, increasing developments in the pharmaceutical industry, and growing demand for novel drugs owing to the prevalence of various infectious diseases. According to US Centers for Medicare & Medicaid Services, the national healthcare expenditure in the US increased by 9.7% in 2019 to reach US$ 4.1 trillion in 2020. National health spending is expected to grow at an annual rate of 5.4% from 2019 to 2028, and it is expected to reach US$ 6.2 trillion by 2028. The rising health expenditure is estimated to increase various funding in the research related to the development of drugs, fueling the North America GMP cell therapy consumables market .
North America GMP Cell Therapy Consumables Market Revenue and Forecast to 2028 (US$ Million)
North America GMP Cell Therapy Consumables Market Segmentation
The North America GMP cell therapy consumables market is segmented on the basis of product, cell therapy, process, end use, and country.
Based on product, the North America GMP cell therapy consumables market is segmented into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest share of the North America GMP cell therapy consumables market in 2022.
Based on cell therapy, the North America GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. The T-cell therapy segment registered the largest share of the North America GMP cell therapy consumables market in 2022.
Based on process, the North America GMP cell therapy consumables market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/quality assurance, and others. The cell collection and characterization/sorting and separation segment held the largest share of the North America GMP cell therapy consumables market in 2022.
Based on end use, the North America GMP cell therapy consumables market is segmented into clinical, commercial, and research. The clinical segment held the largest share of the North America GMP cell therapy consumables market in 2022.
Based on country, the North America GMP cell therapy consumables market is segmented into the US, Canada, and Mexico. The US dominated the North America GMP cell therapy consumables market in 2022.
Bio-Techne Corp, BPS Bioscience Inc, Corning Inc, FUJIFILM Irvine Scientific Inc, Global Life Sciences Solutions USA LLC, Lonza Group AG, Merck KGaA, Miltenyi Biotec BV & Co KG, Sartorius AG, and Thermo Fisher Scientific Inc are the leading companies operating in the GMP cell therapy consumables market in North America.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America GMP cell therapy consumables market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America GMP cell therapy consumables market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the GMP cell therapy consumables market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
The North America GMP cell therapy consumables market is expected to grow from US$ 6,233.00 million in 2022 to US$ 26,093.86 million by 2028; it is estimated to grow at a CAGR of 27.0% from 2022 to 2028.
Growing Regulatory Approvals for Cell and Gene Therapy (CGT) Product Boosts North America GMP Cell
Therapy Consumables Market
The COVID-19 pandemic accelerated the pace of the ongoing developments in cell and gene therapy (CGT). As per the 2019 U.S. Food and Drug Administration (FDA) report, in the last two years, CGT developers submitted ~500 applications to the FDA to initiate clinical trials. Out of those applications, the FDA predicts that ~10-20 CGT products will be approved annually by 2025. Considering the pace with which the therapies are expected to enter the market, the Alliance for Regenerative Medicine expects this industry's revenues to grow at a CAGR of 40% by 2025.
A few of the FDA-approved CGT developments include:
In 2021, FDA approved Breyanzi. Breyanzi is a cell-based gene therapy to treat patients suffering from certain types of large B-cell lymphoma cancer. Each dose is a customized treatment that uses the patient’s T-cells to fight relapsed or refractory disease.
FDA checks the quality of medication products by carefully monitoring manufacturers' compliance with its Current Good Manufacturing Practice (CGMP) regulations. The regulations comprise minimum requirements for the methods, facilities, and controls to be used during the manufacturing, processing, and packing of a product. The regulations confirm that the product is safe for usage and has the ingredients and strength it claims to have. The approval process for new therapy/drug marketing applications includes a review of the manufacturer's compliance with the CGMPs. FDA evaluators and investigators verify whether the firm has the necessary facilities, equipment, and ability to manufacture the drug it intends to market. Therefore, the outlook of the CGT field is promising due to the increased rate of FDA approvals and patient enthusiasm. In addition, continued advances in CGT following GMP will transform the way diseases are treated and modify healthcare delivery on both the individual and industry levels. Hence, the growing regulatory approvals for cell and gene therapy (CGT) product boosts the North America GMP cell therapy consumables market .
Market Overview
North America is one of the most developed regions in the world. North America accounts for the major share of the GMP cell therapy consumables market over the forecast period. The US is expected to hold the major share in the market owing to the surge in drug discovery, increase in R&D activities, and rise in strategic collaborations among market players. Moreover, rising incidences of cancer, infectious diseases, autoimmune disorders, and neurological disorders have augmented the demand for personalized medicine and regenerative medicine, which, in turn, drive the growth of the GMP cell therapy consumables market. The US holds a significant share of the North America GMP cell therapy consumables market. The market growth is due to rising government health expenditure, increasing developments in the pharmaceutical industry, and growing demand for novel drugs owing to the prevalence of various infectious diseases. According to US Centers for Medicare & Medicaid Services, the national healthcare expenditure in the US increased by 9.7% in 2019 to reach US$ 4.1 trillion in 2020. National health spending is expected to grow at an annual rate of 5.4% from 2019 to 2028, and it is expected to reach US$ 6.2 trillion by 2028. The rising health expenditure is estimated to increase various funding in the research related to the development of drugs, fueling the North America GMP cell therapy consumables market .
North America GMP Cell Therapy Consumables Market Revenue and Forecast to 2028 (US$ Million)
North America GMP Cell Therapy Consumables Market Segmentation
The North America GMP cell therapy consumables market is segmented on the basis of product, cell therapy, process, end use, and country.
Based on product, the North America GMP cell therapy consumables market is segmented into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest share of the North America GMP cell therapy consumables market in 2022.
Based on cell therapy, the North America GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. The T-cell therapy segment registered the largest share of the North America GMP cell therapy consumables market in 2022.
Based on process, the North America GMP cell therapy consumables market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/quality assurance, and others. The cell collection and characterization/sorting and separation segment held the largest share of the North America GMP cell therapy consumables market in 2022.
Based on end use, the North America GMP cell therapy consumables market is segmented into clinical, commercial, and research. The clinical segment held the largest share of the North America GMP cell therapy consumables market in 2022.
Based on country, the North America GMP cell therapy consumables market is segmented into the US, Canada, and Mexico. The US dominated the North America GMP cell therapy consumables market in 2022.
Bio-Techne Corp, BPS Bioscience Inc, Corning Inc, FUJIFILM Irvine Scientific Inc, Global Life Sciences Solutions USA LLC, Lonza Group AG, Merck KGaA, Miltenyi Biotec BV & Co KG, Sartorius AG, and Thermo Fisher Scientific Inc are the leading companies operating in the GMP cell therapy consumables market in North America.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America GMP cell therapy consumables market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America GMP cell therapy consumables market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the GMP cell therapy consumables market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Table of Contents
151 Pages
- 1. Introduction
- 1.1 Study Scope
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 North America GMP Cell Therapy Consumables Market – by Product
- 1.3.2 North America GMP Cell Therapy Consumables Market – by Cell Therapy
- 1.3.3 North America GMP Cell Therapy Consumables Market – by End Use
- 1.3.4 North America GMP Cell Therapy Consumables Market – by End Use
- 1.3.5 North America GMP Cell Therapy Consumables Market – by Country
- 2. North America GMP Cell Therapy Consumables Market – Key Takeaways
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. North America GMP Cell Therapy Consumables Market – Market Landscape
- 4.1 Overview
- 4.2 North America PEST Analysis
- 4.3 Experts’ Opinion
- 5. North America GMP Cell Therapy Consumables Market – Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Rise in Research & Development and Drug Discovery
- 5.1.2 Increase in Strategic Collaborations
- 5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies
- 5.3 Market Opportunities
- 5.3.1 Growing Regulatory Approvals for Cell and Gene Therapy (CGT) Product
- 5.4 Future Trends
- 5.4.1 Increasing Clinical Trials and Rising GMP Demand
- 5.5 Impact Analysis
- 6. GMP Cell Therapy Consumables Market – North America Analysis
- 6.1 North America GMP Cell Therapy Consumables Market Revenue Forecast and Analysis
- 7. North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by Product
- 7.1 Overview
- 7.2 North America GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
- 7.3 Kits
- 7.3.1 Overview
- 7.3.2 Kits: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4 Reagents/ Molecular Biology Reagents
- 7.4.1 Overview
- 7.4.2 Reagents/ Molecular Biology Reagents: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 7.5 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers)
- 7.5.1 Overview
- 7.5.2 Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 8. North America GMP Cell Therapy Consumables Market Analysis and Forecasts to 2028 – by Cell Therapy
- 8.1 Overview
- 8.2 North America GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
- 8.3 NK Cell Therapy
- 8.3.1 Overview
- 8.3.2 NK Cell Therapy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 8.4 Stem Cell Therapy
- 8.4.1 Overview
- 8.4.2 Stem Cell Therapy: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 8.5 T-cell Therapy
- 8.5.1 Overview
- 8.5.2 T-cell Therapy: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 9. North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by End Use
- 9.1 Overview
- 9.2 North America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
- 9.3 Clinical
- 9.3.1 Overview
- 9.3.2 Clinical: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 9.4 Commercial
- 9.4.1 Overview
- 9.4.2 Commercial: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 9.5 Research
- 9.5.1 Overview
- 9.5.2 Research: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10. North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – by Process
- 10.1 Overview
- 10.2 North America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
- 10.3 Cell Collection and Characterization/Sorting and Separation
- 10.3.1 Overview
- 10.3.2 Cell Collection and Characterization/ Sorting and Separation: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.4 Cell Culture and Expansion/Preparation
- 10.4.1 Overview
- 10.4.2 Cell Culture and Expansion/Preparation: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.5 Cryopreservation
- 10.5.1 Overview
- 10.5.2 Cryopreservation: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.6 Cell Processing and Formulation
- 10.6.1 Overview
- 10.6.2 Cell Processing and Formulation: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.7 Cell Isolation and Activation
- 10.7.1 Overview
- 10.7.2 Cell Isolation and Activation: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.8 Cell Distribution/Handling
- 10.8.1 Overview
- 10.8.2 Cell Distribution/Handling: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.9 Process Monitoring and Control/Readministration/Quality Assurance
- 10.9.1 Overview
- 10.9.2 Process Monitoring and Control/Readministration/Quality Assurance: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 10.10 Other
- 10.10.1 Overview
- 10.10.2 Other: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- 11. North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 – Country Analysis
- 11.1 Overview
- 11.1.1 North America: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)
- 11.1.1.1 US: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
- 11.1.1.1.1 Overview
- 11.1.1.1.2 US: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
- 11.1.1.1.3 US: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ ‘Million)
- 11.1.1.1.4 US: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ ‘Million)
- 11.1.1.1.5 US: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ ‘Million)
- 11.1.1.1.6 US: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ ‘Million)
- 11.1.1.2 Canada: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
- 11.1.1.2.1 Overview
- 11.1.1.2.2 Canada: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
- 11.1.1.2.3 Canada: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ ‘Million)
- 11.1.1.2.4 Canada: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ ‘Million)
- 11.1.1.2.5 Canada: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ ‘Million)
- 11.1.1.2.6 Canada: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ ‘Million)
- 11.1.1.3 Mexico: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
- 11.1.1.3.1 Overview
- 11.1.1.3.2 Mexico: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
- 11.1.1.3.3 Mexico: GMP Cell Therapy Consumables Market, by Product, 2019–2028 (US$ ‘Million)
- 11.1.1.3.4 Mexico: GMP Cell Therapy Consumables Market, by Cell Therapy, 2019–2028 (US$ ‘Million)
- 11.1.1.3.5 Mexico: GMP Cell Therapy Consumables Market, by End Use, 2019–2028 (US$ ‘Million)
- 11.1.1.3.6 Mexico: GMP Cell Therapy Consumables Market, by Process, 2019–2028 (US$ ‘Million)
- 12. GMP Cell Therapy Consumables Market – Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in GMP Cell Therapy Consumables Market
- 12.3 Inorganic Growth Strategies
- 12.3.1 Overview
- 12.4 Organic Growth Strategies
- 12.4.1 Overview
- 13. Company Profiles
- 13.1 Sartorius AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Thermo Fisher Scientific Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Miltenyi Biotec BV & Co KG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Bio-Techne Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Corning Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 FUJIFILM Irvine Scientific Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Lonza Group AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 BPS Bioscience Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Merck KGaA
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Global Life Sciences Solutions USA LLC
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
- 14. Appendix
- 14.1 About The Insight Partners
- 14.2 Glossary of Terms
- LIST OF TABLES
- Table 1. US: GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
- Table 2. US: GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ ‘Million)
- Table 3. US: GMP Cell Therapy Consumables Market, by End Use– Revenue and Forecast to 2028 (US$ ‘Million)
- Table 4. US: GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ ‘Million)
- Table 5. Canada: GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
- Table 6. Canada: GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ ‘Million)
- Table 7. Canada: GMP Cell Therapy Consumables Market, by End Use– Revenue and Forecast to 2028 (US$ ‘Million)
- Table 8. Canada: GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ ‘Million)
- Table 9. Mexico: GMP Cell Therapy Consumables Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
- Table 10. Mexico: GMP Cell Therapy Consumables Market, by Cell Therapy – Revenue and Forecast to 2028 (US$ ‘Million)
- Table 11. Mexico: GMP Cell Therapy Consumables Market, by End Use– Revenue and Forecast to 2028 (US$ ‘Million)
- Table 12. Mexico: GMP Cell Therapy Consumables Market, by Process – Revenue and Forecast to 2028 (US$ ‘Million)
- Table 13. Recent Inorganic Growth Strategies in the GMP Cell Therapy Consumables Market
- Table 14. Recent Organic Growth Strategies in GMP Cell Therapy Consumables Market
- Table 15. Glossary of Terms
- LIST OF FIGURES
- Figure 1. North America GMP Cell Therapy Consumables Market Segmentation
- Figure 2. North America GMP Cell Therapy Consumables Market, by Country
- Figure 3. North America GMP Cell Therapy Consumables Market Overview
- Figure 4. Kits Segment Held the Largest Share of Product Segment in North America GMP Cell Therapy Consumables Market
- Figure 5. US Expected to Show Remarkable Growth During Forecast Period
- Figure 6. North America: PEST Analysis
- Figure 7. Experts’ Opinion
- Figure 8. North America GMP Cell Therapy Consumables Market: Impact Analysis of Drivers and Restraints
- Figure 9. North America GMP Cell Therapy Consumables Market – Revenue Forecast and Analysis – 2019–2028
- Figure 10. North America GMP Cell Therapy Consumables Market Revenue Share, by Product 2021 & 2028 (%)
- Figure 11. Kits: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 12. Reagents/ Molecular Biology Reagents: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 13. Growth Factors/Cytokines and Interleukins (Including Protein and Nucleic Acid Purification Buffers): North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 14. Others: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 15. North America GMP Cell Therapy Consumables Market, by Cell Therapy 2021 & 2028 (%)
- Figure 16. NK Cell Therapy: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 17. Stem Cell Therapy: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 18. T-cell Therapy: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 19. Other Applications: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 20. North America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
- Figure 21. Clinical: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 22. Commercial: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 23. Research: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 24. North America GMP Cell Therapy Consumables Market Revenue Share, by End User 2021 & 2028 (%)
- Figure 25. Cell Collection and Characterization/Sorting and Separation: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 26. Cell Culture and Expansion/Preparation: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 27. Cryopreservation: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 28. Cell Processing and Formulation: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 29. Cell Isolation and Activation: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 30. Cell Distribution/Handling: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 31. Process Monitoring and Control/Readministration/Quality Assurance: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 32. Other: North America GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 33. North America: GMP Cell Therapy Consumables Market, by Key Country – Revenue (2021) (US$ ‘Million)
- Figure 34. North America: GMP Cell Therapy Consumables Market, by Country, 2021 & 2028 (%)
- Figure 35. US: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
- Figure 36. Canada: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
- Figure 37. Mexico: GMP Cell Therapy Consumables Market – Revenue and Forecast to 2028 (US$ ‘Million)
- Figure 38. Growth Strategies in GMP Cell Therapy Consumables Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
